ArticleMedicine in microecology2022

Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial.

Vicente Navarro-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.